MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Boston Scientific Corporation Gross Profit 2011-2026 | BSX
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Boston Scientific Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.9 B | 11.5 B | 9.9 B | 8.73 B | 8.18 B | 6.45 B | 7.62 B | 7.01 B | 6.46 B | 5.96 B | 5.3 B | 5.17 B | 4.97 B | 4.9 B | 4.96 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.9 B | 4.9 B | 7.4 B |
Quarterly Gross Profit Boston Scientific Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.54 B | 3.42 B | 3.21 B | 2.9 B | 2.85 B | 2.65 B | 2.43 B | 2.54 B | 2.35 B | - | 2.19 B | 2.23 B | 2.07 B | - | 2.03 B | 2.13 B | 1.86 B | - | 1.79 B | 1.21 B | 1.74 B | - | 1.93 B | 1.87 B | 1.76 B | - | 1.72 B | 1.75 B | 1.71 B | - | 1.58 B | 1.62 B | 1.51 B | - | 1.51 B | 1.49 B | 1.39 B | - | 1.35 B | 1.3 B | 1.25 B | - | 1.3 B | 1.31 B | 1.24 B | - | 1.22 B | 1.28 B | 1.18 B | - | 1.18 B | 1.25 B | 1.24 B | - | 1.19 B | 1.29 B | 1.29 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.54 B | 1.18 B | 1.82 B |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
67.9 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
-3.14 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
89.3 M | $ 11.94 | -1.08 % | $ 1.61 B | USA |
 |
Allied Healthcare Products
AHPI
|
443 K | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
22.7 M | $ 9.07 | -3.3 % | $ 257 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
584 K | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
1.65 B | $ 36.67 | -0.19 % | $ 5.46 K | USA |
 |
Apollo Endosurgery
APEN
|
42.4 M | - | - | $ 475 M | USA |
 |
FONAR Corporation
FONR
|
42.4 M | $ 18.58 | -0.11 % | $ 122 M | USA |
 |
EDAP TMS S.A.
EDAP
|
24.4 M | $ 3.4 | -1.73 % | $ 127 M |  France |
 |
Globus Medical
GMED
|
719 M | $ 90.0 | 1.58 % | $ 12.2 B | USA |
 |
CryoLife, Inc.
CRY
|
168 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
2 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
2.8 B | $ 166.87 | -2.91 % | $ 12.5 B | USA |
 |
AxoGen
AXGN
|
167 M | $ 30.99 | -5.06 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
198 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
6.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
28.7 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
43.7 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
1.99 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
48.8 M | $ 4.05 | -1.94 % | $ 857 M | USA |
 |
Intersect ENT, Inc.
XENT
|
50.2 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
26.5 M | $ 0.61 | 3.37 % | $ 38 M | USA |
 |
BIOLASE
BIOL
|
16.7 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
73.4 M | $ 9.67 | -0.31 % | $ 346 M | USA |
 |
Helius Medical Technologies
HSDT
|
61 K | $ 1.83 | -3.68 % | $ 1.11 M | USA |
 |
BioSig Technologies
BSGM
|
229 K | - | 37.08 % | $ 85.7 M | USA |
 |
Alphatec Holdings
ATEC
|
532 M | $ 11.03 | 0.55 % | $ 1.66 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
953 M | $ 9.33 | 0.21 % | $ 719 M | USA |
 |
CONMED Corporation
CNMD
|
750 M | $ 34.54 | 1.35 % | $ 1.07 B | USA |
 |
IRIDEX Corporation
IRIX
|
19.2 M | $ 1.03 | 3.35 % | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
500 M | $ 85.11 | -0.61 % | $ 2.96 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
4.73 B | $ 80.84 | -0.43 % | $ 47.3 B | USA |
 |
Inspire Medical Systems
INSP
|
779 M | $ 54.42 | 0.52 % | $ 1.6 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
173 M | $ 15.76 | -1.13 % | $ 370 M | USA |
 |
LENSAR
LNSR
|
14.1 M | $ 5.63 | -4.41 % | $ 67.3 M | USA |
 |
Conformis
CFMS
|
23.2 M | - | - | $ 16.4 M | USA |
 |
Medtronic PLC
MDT
|
19.6 B | $ 86.42 | 0.15 % | $ 111 B | USA |
 |
Cardiovascular Systems
CSII
|
173 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-12.7 M | - | -10.19 % | $ 1.99 M | USA |
 |
Myomo
MYO
|
26.9 M | $ 0.68 | -2.9 % | $ 28.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
6.01 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
14.3 M | - | - | $ 10.2 M | USA |
 |
Orthofix Medical
OFIX
|
566 M | $ 11.71 | -0.51 % | $ 464 M |  Curacao |
 |
Second Sight Medical Products
EYES
|
500 K | - | -0.97 % | $ 54.4 M | USA |